ERVW-1 and lung adenocarcinoma: A 2023 study found that in a KRAS‐driven lung cancer model with APOBEC3B expression model of lung adenocarcinoma, murine leukemia virus Env glycoproteins were the main target of anti‐tumor antibodies (Table 4).